E-Newsletter

Signup to know about the latest transactions and industry research.

SIGN UP >

"We hired Petsky Prunier because of their transaction experience in the direct marketing and marketing service industries and their relationships with the CEOs of the leading strategic & private equity firms in our market segment. Based on their market knowledge and ongoing dialogue with business leaders, the Petsky Prunier team quickly identified the right target list of potential buyers, ran a disciplined process and not only met but exceeded our expectations on valuation. I would highly recommend them when selling a marketing services company."

Don Patrick
Chief Executive Officer
Merkle, Inc.
Home > Leadership Team > Christopher French, Senior Advisor

Christopher French, Senior Advisor

Christopher French has more than two decades of experience in executive management, strategic planning, M&A advisory services and product marketing. Mr. French leads Winterberry Group's acquisition strategy and private equity firm transaction support practice. He also brings significant expertise advising marketing technology and services firms that support the life science industry. Mr. French has led a number of engagements for leading financial investors (including Alta Communications, American Capital Strategies, and The Carlyle Group) as well as service and technology firms (including Allscripts, MarketBridge, MediMedia USA and Rosetta Marketing).

Prior to joining Winterberry Group, Mr. French served as president and chief executive officer of Cadient Group, a private equity-backed, interactive marketing agency for life science companies. Previously, he served in a number of capacities—including senior vice president of global solutions marketing and corporate development, as well as general counsel—at Dendrite International, a provider of software, information and service solutions to the global life sciences industry. Prior to joining Dendrite, he was a merger and acquisition associate at Skadden, Arps, Slate, Meagher & Flom, a leading global law firm.

Mr. French is a graduate of Fordham University School of Law and received a B.S. in economics from the Wharton School at the University of Pennsylvania. He serves on the Board of Directors of Cadient Group, Health Market Science and the Board of Advisors of Crossix. Mr. French also is a member of the Fordham Law School Advisory Committee and former chairman of the Board of Trustees for the Epiphany School Foundation in New York City.